Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series.
Simone Mornese PinnaSilvia CorcioneAmedeo De NicolòGiorgia MontrucchioSilvia ScabiniDavide VitaIlaria De BenedettoTommaso LupiaJacopo MulaGiovanni Di PerriAntonio D'AvolioFrancesco Giuseppe De RosaPublished in: Antibiotics (Basel, Switzerland) (2022)
A cefiderocol dosage of 2 g q8 h in critically ill patients with AKI undergoing CVVH may bring about a very high plasma concentration, corresponding to essentially 100% free time over the MIC for DTR-AB.